Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseColorectal cancer tumour markers and biomarkers: Recent therapeutic advancesMolecular phenotypes of colorectal cancer and potential clinical applicationsWhat a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathwayMolecular alterations and biomarkers in colorectal cancerCan K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic reviewHow many molecular subtypes? Implications of the unique tumor principle in personalized medicineDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyPrimary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategiesCIViC databaseMolecular predictive markers in tumors of the gastrointestinal tractMechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancerAspirin use, tumor PIK3CA mutation, and colorectal-cancer survivalThe epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic fluxColorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerPrognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysisHypoxia triggers a Nur77-β-catenin feed-forward loop to promote the invasive growth of colon cancer cells.Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic studyBiomarker correlation network in colorectal carcinoma by tumor anatomic location.Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expressionIGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Recurrent inflammatory myofibroblastic tumors harboring PIK3CA and KIT mutations.Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations.Smarter drugs emerging in pancreatic cancer therapy.SMO expression in colorectal cancer: associations with clinical, pathological, and molecular featuresPrediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancerDerivation and validation of homocysteine score in u.s. Men and women.Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive valuePIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.Over-expression of the ATP5J gene correlates with cell migration and 5-fluorouracil sensitivity in colorectal cancer.Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer.Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerPIK3CA mutations predict recurrence in localized microsatellite stable colon cancerLIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans.Evolutionary history of phosphatidylinositol- 3-kinases: ancestral origin in eukaryotes and complex duplication patterns.PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer
P2860
Q24289344-50F31315-9B92-4EC3-A657-CE26342D0967Q26768427-7F31C8B7-2BEE-4128-A963-AB761A15AFA6Q26785725-5BCD4A0A-FF2A-4067-8BF1-BC20E91B4586Q26825780-162F1A8C-B80B-42B0-BA0C-800CD1C2B336Q26862317-B7719465-FD07-43B6-92A5-8BF6894D7395Q26863194-6F0F9185-E8E0-4BFE-AD01-5F56868FEEC9Q26992045-FD79CAFE-0717-45B3-8DBD-32B66B3A3583Q27011884-14D1692F-8B2E-40F9-9ACF-15EE2FAD0FA6Q27015224-F399C92D-E6DE-4948-BC2B-13176EB66151Q27612411-09F7E1D5-4FBB-48B1-B4AA-1298A2063491Q28070583-A4B0DD03-DE1E-4D79-B846-BE7C9F545473Q28076490-7CC19643-6C3A-45D0-8128-C62AAD026CDEQ28277824-514020FE-2D58-4E16-8DC6-1F5DEEB03C27Q28607006-C67E4839-2FF9-4AFD-8386-AD2BFE072C9EQ30238915-CE478CC8-1656-447E-ACCC-AFDFA3523662Q30248900-B64B67DF-0826-44B3-96D9-B3DC2AEABEEEQ30408026-447201C0-50C7-4F87-946B-CB7771FC187BQ33682949-481CF7E3-4422-487A-B70B-7A4A29D4F99EQ33808553-A07EC64E-2334-4502-9BAF-7BD570BB9B81Q33992378-E7B549EC-4A3A-40AD-B8DC-6103C334AB44Q34008641-0E016B1E-E405-4D46-B571-9EB6AFF9EB98Q34016833-85248F76-F152-4AB4-A81C-0CDE5346DCA8Q34028920-AB937802-702A-451B-85C4-16F55D8A1949Q34153696-B0955D5F-9FBE-4650-9B13-C4E398475FC6Q34410212-13A9A5F3-17A4-451D-B7F1-0A7064440D5DQ34458644-8A14D062-FA14-4B1F-B8CD-DF31A3587A9CQ34502713-63B66CBC-EC37-4249-B845-FD782911D3C2Q34631723-8590C291-2DC2-4DDE-A08D-4FA6F246BDD1Q34684240-FD2D5B5C-B4B7-4849-91C1-23F1B72692B1Q34755943-57D61071-CF15-479C-91B3-93523AC3C4ABQ34778710-EAB03A66-BCE8-4F1A-A8D6-DF7F974A9792Q35017086-C7BB408A-18B5-4F85-BE2A-5808C765EDD1Q35137525-0602231B-7609-4240-85FA-6F4A71799893Q35183160-12EBED5C-DE19-4294-8242-35834090FF21Q35191237-B28DC1BA-F85F-4FD7-B7F2-ECD9438E5585Q35198335-7E45E8D6-2533-4B5C-9783-942FAF49FEE0Q35236785-0C2BDD80-CC9E-44E0-B0C5-CA20072D4379Q35635465-724D06E6-C9F2-47D3-BBF9-CE71B6A622E5Q35813677-B12E7580-7544-49F5-B582-A66BA9C7C8B5Q35815544-D3618CDD-FA06-4B9E-828E-3944100590AA
P2860
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@ast
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@en
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@en-gb
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@nl
type
label
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@ast
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@en
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@en-gb
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@nl
altLabel
Prognostic role of PIK3CA muta ...... rt study and literature review
@en
prefLabel
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@ast
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@en
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@en-gb
Prognostic Role of PIK3CA Muta ...... rt Study and Literature Review
@nl
P2093
P2860
P50
P3181
P1476
Prognostic role of PIK3CA muta ...... rt study and literature review
@en
P2093
Aya Kuchiba
Katsuhiko Nosho
Mai Yamauchi
Paul Lochhead
Reiko Nishihara
Teppei Morikawa
Xiaoyun Liao
Yu Imamura
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-11-2410
P407
P577
2012-02-22T00:00:00Z